ABBV vs CC · P/E 81, rev $61.16B vs P/E 72, rev $1.36B
AbbVie Inc (ABBV) versus Chemours Co (CC) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Chemours Co (CC) is a specialty chemicals company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Not investment advice. Open the ABBV and CC stock pages for the full models.
Not investment advice.